Login to Your Account



NewCo News: Making Cancer Feel the 'Heat' Via Immune-Targeted Vaccine

By Jennifer Boggs


Friday, July 15, 2011
A half-dozen biotechs are in the clinic with heat-shock protein (Hsp)-based drugs, but 2008 start-up Heat Biologics is putting a twist on that approach by developing Hsp vaccines capable of inducing and maintaining immune responses against cancer and other diseases.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription